Worldwide free shipping on orders from 100 US dollars. For orders below 100 US dollars, there is a uniform worldwide shipping charge of 30 US dollars.


Antiinflammatory and analgesic effects of Eurycoma longifolia extracts

Young Min Han, Sang-Uk Woo, Min Sun Choi, Yu Na Park, Seung Hyun Kim, Hyungshin Yim & Hye Hyun Yoo


Eurycoma longifolia is one of the most popular herbal medicines in Southeast Asia. The purpose of this study is to evaluate the analgesic and anti-inflammatory effects of the methanolic extract of E. longifolia roots (TA) in vivo and to investigate the underlying mechanisms. TA was tested for analgesic activity by the hot plate test and acetic acid test in mice. The anti-inflammatory effect of TA was observed in carrageenan-induced paw edema in mice. The in vitro molecular study using macrophage cells was performed to elucidate the relevant mechanism. The analgesic activity of 400 mg/kg TA was higher than that of aspirin in the hot plate test. TA also showed analgesic effects in the acetic acid test in a dose-dependent manner. In carrageenan-induced edema in mice, TA showed an anti-inflammatory effect comparable to that of diclofenac. Further in vitro molecular study using macrophage cells revealed that TA suppressed NF-κB translocation to the nucleus, leading to inactivation of the NF-κB signaling pathway and reduction in the expression of cyclooxygenase-2 and inducible nitric oxide synthase. These results exhibited the beneficial effects of TA for alleviating pain and inflammation, which were exerted through inactivation of the NF-κB signaling pathway.


  1. Bedir E, Abou-Gazar H, Ngwendson JN, Khan IA (2003) Eurycomaoside: a New Quassinoid-Type Glycoside from the Roots of Eurycoma longifolia. Chem Pharm Bull 51:1301–1303

  2. Bhat R, Karim AA (2010) Tongkat Ali (Eurycoma longifolia Jack): a review on its ethnobotany and pharmacological importance. Fitoterapia 81:669–679

  3. Chan KL, Choo CY, Morita H, Itokawa H (1998) High performance liquid chromatography in phytochemical analysis of Eurycoma longifolia. Planta Med 64:741–745

  4. Guo Z, Vangapandu S, Sindelar RW, Walker LA, Sindelar RD (2005) Biologically active quassinoids and their chemistry: potential leads for drug design. Curr Med Chem 12:173–190

  5. Han YM, Kim IS, Rehman SU, Choe K, Yoo HH (2015a) In vitro evaluation of the effects of Eurycoma longifolia extract on CYP-mediated drug metabolism. Evid Based Complement Alternat Med 2015:631329

  6. Han YM, Jang M, Kim IS, Kim SH, Yoo HH (2015b) Simultaneous quantitation of six major quassinoids in Tongkat Ali dietary supplements by liquid chromatography with tandem mass spectrometry. J Sep Sci 38:2260–2266

  7. Hajjouli S, Chateauvieux S, Teiten MH, Orlikova B, Schumacher M, Dicato M, Choo CY, Diederich M (2014) Eurycomanone and eurycomanol from Eurycoma longifolia Jack as regulators of signaling pathways involved in proliferation, cell death and inflammation. Molecules 19:14649–14666

  8. Hoesel B, Schmid JA (2013) The complexity of NF-kB signaling in inflammation and cancer. Mol Cancer 12:1–15. doi:10.1186/1476-4598-12-86

  9. Low BS, Choi SB, Abdul-Wahab H, Das PK, Chan KL (2013) Eurycomanone, the major quassinoid in Eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis. J Ethnopharmacol 149:201–207

  10. Mitsunaga K, Koike K, Tanaka T, Ohkawa Y, Kobayashi Y, Sawaguchi T, Ohmoto T (1994) Canthin-6-one alkaloids from Eurycoma longifolia. Phytochemistry 35:799–802

  11. Miyake K, Tezuka Y, Awale S, Li F, Kadota S (2009) Quassinoids from Eurycoma longifolia. J Nat Prod 72:2135–2140

  12. Morita H, Kishi E, Takeya K, Itokawa H, Tanaka O (1990) New quassinoids from the roots of Eurycoma longifolia. Chem Lett 19:749–752

  13. Morita H, Kishi E, Takeya K, Itokawa H, Iitaka Y (1993) Squalene derivatives from Eurycoma longifolia. Phytochemistry 34:765–771

  14. Ojewole JA (2007) Analgesic, anti-inflammatory and hypoglacaemic effects of Rhus chirindensis (Baker F.) [Anacardiaceae] stem-bark aqueous extract in mice and rats. J Ethnopharmacol 113:338–345

  15. Park S, Nhiem NX, Kiem PV, Minh CV, Tai BH, Kim N, Yoo HH, Song JH, Ko HJ, Kim SH (2014) Five new quassinoids and cytotoxic constituents from the roots of Eurycoma longifolia. Bioorg Med Chem Lett 24:3835–3840

  16. Patrignani P, Patrono C (2014) Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta 1851:422–432

  17. Tada H, Yasuda F, Otani K, Doteuchi M, Ishihara Y, Shiro M (1991) New antiulcer quassinoids from Eurycoma longifolia. Eur J Med Chem 26:345–349

  18. Tak PP, Firestein GS (2001) NF-kB: a key role in inflammatory diseases. J Clin Investig 107:7–11

  19. Tran TV, Malanier C, Schwaiger S, Atanasov AG, Heiss EH, Dirsch VM, Stuppner H (2014) NF-kB inhibitors from Eurycoma longifolia. J Nat Prod 77:483–488

  20. Wong PF, Cheong WF, Shu MH, Teh CH, Chan KL, AbuBakar S (2012) Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine 19:138–144

Download references


This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2014R1A1A1A05002840 and NRF-2014R1A2A1A11049701).

Author information

Correspondence to Hyungshin Yim or Hye Hyun Yoo.

Ethics declarations

PT Sumatra Pasak Bumi
Dusun 4 Tuntungan 1 Pancur Batu
Deli Serdang
North Sumatra 20353
Tel: +62-813 800 800 20

Disclaimer: Statements and products on this page have not undergone the FDA approval process.

Privacy policy of Sumatra Pasak Bumi